ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,215Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 208

$3.94M Total Retail Price of All Prescriptions

Rank: 4 out of 208

195 Patients Receiving at Least One Drug in Part D
11%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 195 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

44% of this provider’s 195 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 1,327 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 43%.

Prescription Price

$351 was the average price of a prescription from this provider, compared to $300 among peers.

Prescriptions per Patient

58 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
TRUVADA 554 13 1 2
NORVIR 488 54 2 1
ISENTRESS 362 37 3 4
EPZICOM 349 70 4 10
GABAPENTIN 278 25 5 13
ACYCLOVIR 265 0 6 17
OMEPRAZOLE 254 51 7 8
PREZISTA 239 12 8 7
PRAVASTATIN SODIUM 231 49 9 18
LISINOPRIL 206 48 10 5
ANDROGEL 181 11 S3 11 30
HYDROCODONE-ACETAMINOPHEN 174 0 S3 12 3
REYATAZ 174 26 12 6
TESTOSTERONE CYPIONATE 170 15 S3 14 60
FLUCONAZOLE 153 0 15 28
IBUPROFEN 152 0 16 33
INTELENCE 146 12 17 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 145 0 18 21
FLUTICASONE PROPIONATE 130 21 19 57
VIRAMUNE 130 29 10 19 89
LEXIVA 127 16 21 69
PROAIR HFA 125 0 22 43
AZITHROMYCIN 120 12 23 56
METFORMIN HCL 119 22 24 15
TAMSULOSIN HCL 118 35 25 34
VIREAD 101 23 26 26
OXANDROLONE 99 11 10 27 108
DRONABINOL 95 0 28 75
TRAZODONE HCL 90 14 29 38
ZOLPIDEM TARTRATE 90 0 29 20
RANITIDINE HCL 87 0 31 48
VALACYCLOVIR 86 0 32 41
TRIAMCINOLONE ACETONIDE 86 0 32 62
KETOCONAZOLE 85 11 34 97
VIRAMUNE XR 83 0 35 42
CYMBALTA 74 0 36 66
GEMFIBROZIL 73 0 37 74
KALETRA 73 0 37 31
IMIQUIMOD 72 0 39 189
FLUOXETINE HCL 72 18 39 104
MIRTAZAPINE 71 13 41 111
BACLOFEN 70 12 42 83
ATRIPLA 68 0 43 16
SELZENTRY 67 0 44 63
SUMATRIPTAN SUCCINATE 63 0 45 202
LEVOFLOXACIN 59 0 46 67
HYDROCORTISONE 58 0 47 214
OXYCODONE HCL 56 0 S2 48 158
HYDROCHLOROTHIAZIDE 56 0 48 19
QUETIAPINE FUMARATE 55 0 50 222
ALENDRONATE SODIUM 55 0 50 39
NEVIRAPINE 54 12 10 52 124
FAMCICLOVIR 54 0 52 151
NAPROXEN 54 0 52 70
CLINDAMYCIN PHOSPHATE 53 0 55 227
DIPHENOXYLATE-ATROPINE 53 0 55 72
ATENOLOL 51 0 57 22
AMLODIPINE BESYLATE 50 13 58 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.